Ascendis Pharma AS

Stock Chart, Company Information, and Scan Results

$260.88(as of Jul 17, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ascendis Pharma AS Company Information, Fundamentals, and Technical Indicators

Stock Price$260.88
Ticker SymbolASND
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees1,189
CountyUSA
Market Cap$17,334.2M

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Ascendis Pharma AS In Our Stock Scanner

As of Jul 17, 2026
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.